Houston, Louisiana Clinical Trials

A listing of Houston, Louisiana clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
Azacitidine Venetoclax and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome

This phase II trial investigates how well azacitidine, venetoclax, and trametinib work in treating patients with acute myeloid leukemia or higher-risk myelodysplastic syndrome that has come back (relapsed) or has not responded to treatment (refractory). Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer …

leukemia recurrent
myelodysplastic syndrome
HRAS
chronic myelomonocytic leukemia
recurrent chronic myelomonocytic leukemia
M D Anderson Cancer Center
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

This is a multicenter, open-label Phase 1 study of orally administered CB-5339 in participants with R/R AML or participants with R/R intermediate- to high-risk MDS.

remission
myelodysplastic syndrome
acute myeloid leukemia
hematologic malignancy
cytopenia
MD Anderson Cancer Cancer
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

pneumonia
treatment regimen
oxygen supplementation
x-rays
nitric oxide
Houston Methodist
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +13 other locations
Osimertinib With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

This phase Ib trial studies the side effects and best dose of alisertib or sapanisertib, in combination with osimertinib, in treating patients with EGFR mutated stage IIIB or IV non-small cell lung cancer that remains despite treatment with osimertinib (osimertinib resistant). Osimertinib, alisertib, and sapanisertib may stop the growth of …

tyrosine
hemoglobin a1c
measurable disease
recurrent nsclc
metastasis
M D Anderson Cancer Center
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

combined modality therapy
taxane
antiandrogens
prostatic neoplasm
combination therapy
MD Anderson Cancer Center
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
DeBakey Cardiovascular Magnetic Resonance Study

While advancements in cardiac magnetic resonance (CMR) have improved image quality, it is unclear how these improvements are connected to the clinical evaluation of individuals with cardiovascular disease. The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to gain additional pathophysiologic insights into cardiovascular …

heart disease
cardiovascular disease
vascular disease
Houston Methodist Hospital
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

datscan
resting tremor
modafinil
methyldopa
muscle rigidity
Baylor College of Medicine
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
VENOUS: A Translational Study of Enterococcal Bacteremia

The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect …

MD Anderson Cancer Center
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +11 other locations
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may …

cancer
covid-19
M D Anderson Cancer Center
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Natural History Study of MNGIE

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Baylor St Luke's Medical Center and Texas Children's Hospital at Baylor College of Medicine
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations